Sarah M. Bartsch

Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention

Sarah M. Bartsch, Kelly J. O’Shea, Marie C. Ferguson et al. · American Journal of Preventive Medicine · 2020 · 349 citations · Full text

Vaccination, Vaccine Safety, Covid-19 Pandemic +8

Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States

Sarah M. Bartsch, James A. McKinnell, Leslie E. Mueller et al. · Clinical Microbiology and Infection · 2016 · 213 citations · Full text

Health Sciences, Health Economics, Klebsiella Pneumoniae +8

Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities — United States

Rachel B. Slayton, Damon Toth, Bruce Y. Lee et al. · MMWR Morbidity and Mortality Weekly Report · 2015 · 159 citations

Is Fidaxomicin Worth the Cost? An Economic Analysis

Sarah M. Bartsch, Craig A. Umscheid, Neil O. Fishman et al. · Clinical Infectious Diseases · 2013 · 106 citations · Full text

Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases

T. Déirdre Hollingsworth, Emily R. Adams, Roy M. Anderson et al. · Parasites & Vectors · 2015 · 90 citations · Full text